TSH of 5.32 mIU/L in a Woman on Levothyroxine 100 mcg: Inadequate Treatment Requiring Dose Adjustment
Yes, she has inadequately treated hypothyroidism—her levothyroxine dose needs to be increased to bring her TSH into the normal reference range (typically 0.4-4.2 mIU/L). 1
Clinical Context and Interpretation
A TSH of 5.32 mIU/L in a patient already taking levothyroxine 100 mcg daily represents subclinical hypothyroidism in a treated patient, which is fundamentally different from untreated subclinical hypothyroidism. The FDA labeling is explicit: when subclinical hypothyroidism is noted in levothyroxine-treated patients with overt hypothyroidism, the dosage should be adjusted to bring serum TSH into the reference range. 1
Why This Matters
- Persistent elevation of TSH despite treatment indicates inadequate replacement therapy and may reflect inadequate absorption, poor compliance, drug interactions, or simply insufficient dosing. 1
- The goal of levothyroxine therapy in patients with established hypothyroidism is to normalize TSH to within the reference range (0.4-4.2 mIU/L). 1, 2
- Recent evidence demonstrates that mortality increases when TSH remains outside the normal reference range in treated hypothyroid patients—both when too high and too low. 3
Recommended Management Algorithm
Step 1: Assess Compliance and Absorption Issues
Before increasing the dose, evaluate: 1
- Medication adherence: Is she taking it consistently on an empty stomach, 30-60 minutes before breakfast?
- Drug interactions: Coffee, calcium, iron, proton pump inhibitors, and many other medications interfere with levothyroxine absorption
- Gastrointestinal conditions: Celiac disease, atrophic gastritis, or inflammatory bowel disease can impair absorption
Step 2: Increase Levothyroxine Dose
If compliance and absorption are adequate: 1
- Increase by 12.5-25 mcg per day (to 112.5 or 125 mcg daily)
- Monitor TSH after 6-8 weeks following any dose change
- Continue adjusting until TSH is within the normal reference range
Step 3: Consider Special Circumstances
If she is pregnant or planning pregnancy: 4, 1
- This is urgent—increase dose immediately by 25-30% (approximately 25-30 mcg increase)
- Monitor TSH every 4 weeks during pregnancy
- Maintain TSH within trimester-specific reference ranges to prevent fetal neuropsychological complications
If she is elderly or has cardiovascular disease: 1
- Use smaller dose increments (12.5 mcg)
- Monitor for cardiac symptoms (angina, arrhythmias, palpitations)
- Accept TSH in the upper portion of normal range if symptomatic with lower TSH
Important Distinction: Treated vs. Untreated Subclinical Hypothyroidism
The guidelines stating that TSH 4.5-10 mIU/L may not require treatment apply only to previously untreated patients with newly discovered subclinical hypothyroidism. 4 Those guidelines do not apply here because:
- She is already on levothyroxine therapy, indicating established hypothyroidism requiring treatment
- The treatment goal for patients on levothyroxine is TSH normalization, not observation 1
- Leaving TSH elevated in treated patients increases mortality risk 3
Common Pitfalls to Avoid
Do not confuse this with untreated subclinical hypothyroidism: The 2004 JAMA guidelines recommending observation for TSH 4.5-10 mIU/L apply only to treatment-naive patients, not those already on replacement therapy. 4
Do not accept "upper normal" TSH as adequate: While some patients may feel well with TSH in the upper half of normal, a TSH of 5.32 is above the reference range and requires adjustment. 1, 2
Do not overlook medication timing: Many patients take levothyroxine incorrectly (with food, coffee, or other medications), which can explain persistent TSH elevation despite seemingly adequate dosing. 5